| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 176.7K | $12.84M | - | |
| CEO | 80.5K | $5.85M | - | |
| Dir | 80.0K | $5.81M | - | |
| Dir | 59.6K | $4.33M | - | |
| Pres | 25.0K | $1.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 10, 2019 | Charles R. Kummeth77 | Chief Executive Officer | Sale+OE | 703 | $222.01 | $156,073.03 | -0.5% | |
| Dec 4, 2019 | Harold J Wiens | Director | Sale+OE | 2,000 | $217.85 | $435,692.83 | -27.7% | |
| Nov 29, 2019 | Charles R. Kummeth77 | Chief Executive Officer | Sale+OE | 11,872 | $222.13 | $2,637,076.66 | -8.0% | |
| Nov 25, 2019 | Roeland Nusse51 | Director | Sale+OE | 8,347 | $219.33 | $1,830,730.82 | -40.3% | |
| Nov 22, 2019 | James Hippel74 | Chief Financial Officer | Sale+OE | 35,000 | $215.52 | $7,543,033.38 | -79.0% | |
| Sep 9, 2019 | Charles R. Kummeth77 | Chief Executive Officer | Buy | 200 | $185.00 | $37,000.00 | -200.0% | |
| Aug 7, 2019 | Robert V Baumgartner45 | Director | Buy | 500 | $191.06 | $95,530.00 | +6.1% | |
| Jul 10, 2019 | Charles R. Kummeth77 | Chief Executive Officer | Sale+OE | 16,969 | $213.12 | $3,616,428.34 | -15.5% | |
| Jul 9, 2019 | Charles R. Kummeth77 | Chief Executive Officer | Sale+OE | 33,031 | $212.60 | $7,022,523.90 | -26.4% | |
| Jun 12, 2019 | Norman David Eansor52 | SVP - Novus Biologicals | Sell | 3,117 | $215.00 | $670,155.00 | -100% |